Andrew Hessel — SPARQNOW

At-a-Glance

Serves as Chairman, Co-Executive Director, and Co-founder of Genome Project-write (GP-write) and The Center of Excellence for Engineering Biology (CEEB) since 2019.
Co-founded Humane Genomics Inc. in 2017, which uses synthetic virus engineering to target cancer cells.
Founded Pink Army Cooperative in 2009, focused on open source viral therapies for cancer.
Co-founded Miikana Therapeutics in 2002, a clinical-stage drug development company.
Served as a Distinguished Researcher in the Bio/Nano Programmable Matter department at Autodesk from 2012 to 2018.
Received an M.Sc. in biology from the University of Calgary in 1995.

Biography

Andrew Hessel is a pioneer in synthetic biology, a geneticist, and an entrepreneur, known for his work in programming life and advocating for open source biology. He currently serves as Chairman, Co-Executive Director, and Co-founder of the Genome Project-write (GP-write) and The Center of Excellence for Engineering Biology (CEEB) since 2019. Hessel was a catalyst behind GP-write, which he co-founded in 2016 with George Church, Nancy J.